PMID: 29750886May 12, 2018Paper

Co-administration of conjugated linoleic acid and rosiglitazone increases atherogenic co-efficient and alters isoprenaline-induced vasodilatation in rats fed high fat diet

Physiological Research
B K ChaiS K Mohankumar

Abstract

The cis(c)-9, trans(t)-11 (c9,t11) and t10,c12 isomers of conjugated linoleic acid (CLA) have been reported as agonists of peroxisome proliferator-activated receptor (PPAR) and beneficial in lipidemia and glycemia. However, it is unclear whether CLA isomers enhance or antagonize effects of conventional drugs targeting PPAR. Male Sprague-Dawley rats were fed high fat diet (HFD) for 8 weeks and treated without or with CLA, rosiglitazone or both for 4 weeks. Oral glucose tolerance and surrogate markers of insulin resistance were not significantly different for all treatments compared to untreated normal diet (ND) or HFD group, except lipoprotein levels. The combination of CLA and rosiglitazone had suppressed levels of low and high density lipoproteins (46 % and 25 %, respectively), compared to HFD-alone. Conversely, the atherogenic co-efficient of the animals received HFD or HFD+rosiglitazone+CLA was 2-folds higher than ND, HFD+rosiglitazone or HFD+CLA. Isolated aortic rings from the combined CLA and rosiglitazone treated animals were less sensitive to isoprenaline-induced relaxation among endothelium-denuded aortas with a decreased efficacy and potency (R(max)=53+/-4.7 %; pEC50=6+/-0.2) compared to endothelium-intact aortas (R(ma...Continue Reading

References

Oct 31, 1991·Biochemical and Biophysical Research Communications·J BernhardtT F Lüscher
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J L DixonM Sturek
Dec 29, 2000·European Journal of Nutrition·A H StarkZ Madar
Dec 7, 2002·Hypertension·Dhananjay N UmraniMustafa F Lokhandwala
Sep 13, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Laura CalabresiGuido Franceschini
May 26, 2004·The American Journal of Clinical Nutrition·Carla G Taylor, Peter Zahradka
Jan 15, 2005·Clinical and Experimental Pharmacology & Physiology·Satomi KagotaKazumasa Shinozuka
Jan 9, 2007·Lipids in Health and Disease·Danik M MartirosyanVladimir I Zoloedov
Feb 27, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Li-Fen LiuMartha A Belury
Mar 14, 2007·Circulation·John E DeanfieldTon J Rabelink
May 23, 2007·The New England Journal of Medicine·Steven E Nissen, Kathy Wolski
Jun 24, 2008·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Phoebe A StapletonJefferson C Frisbee
Oct 23, 2008·Cell and Tissue Research·Wineke BakkerVictor W M van Hinsbergh
Feb 21, 2009·Nature Clinical Practice. Endocrinology & Metabolism·Arshag D Mooradian
May 22, 2009·Digestive Diseases and Sciences·Zheng-Jie XuGuo-Liang Wang
Jan 12, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·William SchwingHarris C Taylor
Mar 26, 2010·Tissue Engineering. Part B, Reviews·Jeffrey A BeamishRoger E Marchant
May 6, 2011·Diabetes Care·Angelo AvogaroGian Paolo Fadini
Jun 21, 2011·The Journal of Nutritional Biochemistry·Vanessa DeClercqPeter Zahradka
Sep 24, 2011·The British Journal of Nutrition·V DeClercqP Zahradka
Mar 29, 2012·Critical Reviews in Food Science and Nutrition·Allison Dilzer, Yeonhwa Park
Jul 21, 2012·The Journal of Pharmacology and Experimental Therapeutics·Ding ZhaoVirginia L Brooks
Sep 3, 2013·The New England Journal of Medicine·William R HiattRobert J Smith
Sep 3, 2013·Biochimica Et Biophysica Acta·Cristina M SenaRaquel Seiça
Dec 18, 2013·Journal of Leukocyte Biology·Iván BallesterosMaría A Moro
Apr 9, 2014·Cardiology Research and Practice·Jaspinder Kaur
Nov 26, 2014·Molecular Nutrition & Food Research·Concha F García-PrietoMaría S Fernández-Alfonso

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.